Processa Pharmaceuticals, Inc. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
Processa Pharmaceuticals, Inc. (PCSA) had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $8.22 million as of 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2014-05-14
- 2014-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $8.22M.
- 2013-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $6.81M.
- 2013-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $5.96M.
- 2013-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $5.03M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) |
|---|---|
| 2014-03-31 | $8.22M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $6.81M 10-Q · filed 2014-05-14 |
| 2013-09-30 | $5.96M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $5.03M 10-Q/A · filed 2013-09-06 |
| 2012-12-31 | $3.43M 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |